89bio, Inc. (ETNB)
Oct 30, 2025 - ETNB was delisted (reason: acquired by RHHBY)
14.84
0.00 (0.00%)
Inactive · Last trade price on Oct 29, 2025

89bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-174.61-142.19-102.03-90.12-49.5-57.42
Depreciation & Amortization
0.050.050.070.080.060.02
Stock-Based Compensation
18.5916.1110.368.683.810.39
Other Adjustments
-8.22-3.81-0.041.330.4330.62
Changes in Accounts Payable
6.87-3.925.664.781.13-0.52
Changes in Accrued Expenses
3.357.881.754.151.433.45
Changes in Other Operating Activities
-15.55-3.33.15-5.67-3.6-1.99
Operating Cash Flow
-165.54-129.19-81.09-76.78-46.24-25.46
Capital Expenditures
--0-0.01-0.06-0.13-0.14
Purchases of Investments
-390.71-341.15-152.7-141.2-118.9-
Proceeds from Sale of Investments
313.34218.13118.76148.4212.19-
Investing Cash Flow
-77.37-123.02-33.947.16-106.83-0.14
Long-Term Debt Issued
-24.36-19.95--
Long-Term Debt Repaid
--21.4----
Net Long-Term Debt Issued (Repaid)
-2.96-19.95--
Issuance of Common Stock
0.18512.42118.133.92158.0987.7
Repurchase of Common Stock
-3.31-2.28-0.3---
Net Common Stock Issued (Repurchased)
-3.13510.15117.833.92158.0987.7
Issuance of Preferred Stock
-----20
Net Preferred Stock Issued (Repurchased)
-----20
Other Financing Activities
-----0.16-
Financing Cash Flow
209.68513.11117.8323.87157.92107.7
Net Cash Flow
-33.22260.912.8-45.754.8582.1
Beginning Cash & Cash Equivalents
245.4455.2652.4698.2193.3611.26
Ending Cash & Cash Equivalents
212.22316.1655.2652.4698.2193.36
Free Cash Flow
-165.54-129.19-81.1-76.84-46.37-25.6
Free Cash Flow Per Share
-1.88-1.82-2.33-3.82-2.88-10.92
Levered Free Cash Flow
-179.89-138.52-91.41-66.9-50.61-56.61
Unlevered Free Cash Flow
-201.14-154.73-91.65-86.33-50.46-25.83
Updated May 2, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q